Care Delivery

If physicians caring for Medicare fee-for-service patients were all high-value physicians, the federal program could cut healthcare costs by a whopping $286.8 billion from 2020 to 2029, according to UnitedHealth Group. For 2020 alone, Medicare could save more than $20 billion if all physicians were considered high value.

In another sign of its trek into the healthcare space, Amazon has opened a virtual care clinic for its Seattle-based employees, with in-home or in-office follow-ups.

Medicare Advantage premiums are expected to drop 23% from 2018 levels ahead of the new enrollment period, CMS announced, stating that plan choices, benefits and enrollment have increased.

Catch up on some of the healthcare industry’s most recent investment rounds.

 

The number of lung injury cases reported from around the country has risen to 530, according to the CDC’s latest update. The number of reported deaths has been upped to seven, as of September 19.

Highly concentrated markets in the commercial health insurance industry are on the rise, leaving millions more Americans with limited choices when it comes to getting coverage, according to the American Medical Association.

The American Medical Association is joining forces with healthcare groups to urge policymakers to make changes to remove barriers to opioid addiction treatment.

Civica Rx, a not-for-profit drug company with $100 million in funding that aims to combat drug shortages, has inked its next deal with Exela Pharma Sciences to supply its membership of hospitals with sodium bicarbonate injections.

The rate of uninsured Americans in 2018 rose for the first time since the Affordable Care Act went into place, according to new data from the Census Bureau.

Technology giant Apple has announced three new medical studies it will be involved in with major names in the healthcare space, including leading academic and research institutions.

The reputation of the pharmaceutical industry is tanking among U.S. consumers, the latest Gallup poll reveals.

New gene therapies are carrying price tags in the millions, leaving insurers scrambling to figure out how to cover them and offer the treatments to enrollees, according to The Wall Street Journal.